EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

GSDMB as a Therapeutic and Prognostic Target in Clear Cell Renal Cell Carcinoma: Insights From Pyroptosis-Related Gene Analysis

Guijiao Li, Yuerong Li, Wu Xu, Lingfei Yan, Qi Xiang, Yang Luo, Yufeng Liu, Qing Li, Cuilian Li, Tao Wang

Frontiers in Bioscience-Landmark · 17.07.2026 · 31 (7)

DOI: 10.31083/fbl51233 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Frontiers in Bioscience-Landmark, online erschienen am 17.07.2026. Verfasst von Guijiao Li und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China. Hauptthemen laut MEDLINE: Pyroptosis, Carcinoma, Renal Cell, Kidney Neoplasms, Biomarkers, Tumor. Die Arbeit nennt 40 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Project of Administration of Traditional Chinese Medicine of Guangdong Province of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background:Recent research has identified pyroptosis as a distinct form of programmed cell death that is strongly correlated with tumor outcomes. However, its value as a prognostic biomarker in clear cell renal cell carcinoma (ccRCC) is not yet fully established.Methods:Differential expression of pyroptosis-related genes between ccRCC and normal tissues was identified using the DESeq2 R package. Next, univariate and least absolute shrinkage and selection operator (LASSO) Cox regression analyses using data from The Cancer Genome Atlas cohort were applied to develop a prognostic model. Univariate and multivariate prognostic analyses were conducted to determine whether the risk score could independently predicted patient prognosis after adjustment for clinicopathological characteristics. A nomogram was then constructed to estimate patient survival probability, supporting clinical decision-making. Expression of pyroptosis-related proteins was assessed using tissue proteomic data from the Clinical Proteomic Tumor Analysis Consortium (CPTAC) database. Additionally, the Tumor-Immune System Interaction Database (TISIDB) database was used to analyze immune cell infiltration, whereas gasdermin B (GSDMB) expression in ccRCC cell lines was assessed by Western blot (WB) and quantitative PCR (qPCR) experiments, with immunohistochemistry applied to measure the levels of GSDMB and programmed cell death protein 1 (PD-1).Results:A prognostic risk model was developed using nine genes related to pyroptosis (AIM2, CASP5, GSDMB, GSDMD, NLRP7, NOD2, PYCARD, SCAF11, and NLRP6), employing both univariate Cox and LASSO regression analyses. Based on the median risk score, ccRCC samples were divided into high- and low-risk categories, with Kaplan-Meier analysis revealing poorer survival rates for the high-risk group. Time-dependent receiver operating characteristic curve analysis confirmed the predictive performance of the model for ccRCC prognosis. Furthermore, a nomogram with calibration plots was developed to predict 1-, 3-, and 5-year survival probabilities for patients with ccRCC. Notably, these pyroptosis-related genes were strongly correlated with immune cell infiltration, including cytotoxic cells, CD56bright natural killer cells, and T helper cells. Subsequently, qPCR and WB analyses confirmed elevated GSDMB expression in ccRCC cells, and immunohistochemistry demonstrated a strong correlation between GSDMB and PD-1 expression.Conclusions:Pyroptosis-associated genes, namely AIM2, CASP5, GSDMB, GSDMD, NLRP7, NOD2, PYCARD, SCAF11, and NLRP6, are promising prognostic biomarkers for ccRCC, and may serve as prognostic biomarkers for predicting patient survival and informing immunotherapy strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

PyroptosisCarcinoma, Renal CellKidney NeoplasmsBiomarkers, TumorPhosphate-Binding ProteinsHumansGasderminsPrognosisFemaleGene Expression Regulation, NeoplasticMaleCell Line, TumorNomogramsMiddle AgedGene Expression Profiling

Stichwörter der Autor:innen

LASSO Cox regressiongasdermin Bimmune infiltrationprognostic modelpyroptosis

Substanzen

GasderminsBiomarkers, TumorGSDMB protein, humanPhosphate-Binding Proteins

Autor:innen und Institutionen

  • Department of Urology, The Fifth Affiliated Hospital, Southern Medical University, 510900 Guangzhou, Guangdong, China.
  • Medical Research Institute, Guangdong Provincial People's Hospital, Guangdong Academy of Medical Sciences, Southern Medical University, 510900 Guangzhou, Guangdong, China.

Förderung

  • Project of Administration of Traditional Chinese Medicine of Guangdong Province of China

Zitieren

APA

Li, G., Li, Y., Xu, W., Yan, L., Xiang, Q., Luo, Y., Liu, Y., Li, Q., Li, C., & Wang, T. (2026). GSDMB as a Therapeutic and Prognostic Target in Clear Cell Renal Cell Carcinoma: Insights From Pyroptosis-Related Gene Analysis. Frontiers in Bioscience-Landmark, 31(7). https://doi.org/10.31083/fbl51233

Vancouver

Li G, Li Y, Xu W, Yan L, Xiang Q, Luo Y, et al. GSDMB as a Therapeutic and Prognostic Target in Clear Cell Renal Cell Carcinoma: Insights From Pyroptosis-Related Gene Analysis. Frontiers in Bioscience-Landmark. 2026;31(7). doi:10.31083/fbl51233

BibTeX
@article{Li2026,
  author = {Li, Guijiao and Li, Yuerong and Xu, Wu and Yan, Lingfei and Xiang, Qi and Luo, Yang and Liu, Yufeng and Li, Qing and Li, Cuilian and Wang, Tao},
  title = {GSDMB as a Therapeutic and Prognostic Target in Clear Cell Renal Cell Carcinoma: Insights From Pyroptosis-Related Gene Analysis},
  journal = {Frontiers in Bioscience-Landmark},
  year = {2026},
  volume = {31},
  number = {7},
  doi = {10.31083/fbl51233}
}
Kostenlos starten →